Suppr超能文献

低饱和脂肪、低胆固醇鱼油补充剂对高甘油三酯血症患者的影响。一项安慰剂对照试验。

Effects of a low saturated fat, low cholesterol fish oil supplement in hypertriglyceridemic patients. A placebo-controlled trial.

作者信息

Harris W S, Dujovne C A, Zucker M, Johnson B

机构信息

University of Kansas Medical Center, Kansas City.

出版信息

Ann Intern Med. 1988 Sep 15;109(6):465-70. doi: 10.7326/0003-4819-109-6-465.

Abstract

STUDY OBJECTIVE

To determine the effects of fish oil supplements low in saturated fat and cholesterol on plasma lipid and lipoprotein levels in hypertriglyceridemic patients.

DESIGN

Single-blind, placebo-controlled (safflower oil), crossover trial with 6-week treatment periods.

SETTING

Outpatient lipid clinic in a university medical center.

PATIENTS

Eleven adult patients had isolated hypertriglyceridemia (type IV) and seven had concomitant hypercholesterolemia (Type IIb).

INTERVENTION

Twelve 1-g capsules of either fish oil or placebo (safflower oil) were taken daily during each treatment period.

MEASUREMENTS AND MAIN RESULTS

Blood was drawn at the fifth and sixth week of each period and analyzed for total lipids; cholesterol in very low, low (LDL), and high density (HDL) lipoproteins (mmol/L); and apoprotein B (mg/dL). Compared with the placebo, fish oil lowered plasma triglyceride levels (4.0 +/- 1.8 to 2.5 +/- 1.0), and raised LDL cholesterol levels (3.7 +/- 1.75 to 4.25 +/- 0.85), apolipoprotein B levels (122 +/- 29 to 140 +/- 34), and the ratio of LDL cholesterol to HDL cholesterol (4.0 +/- 0.9 to 4.7 +/- 1.4) (P less than 0.05; mean +/- SD). No significant changes were seen in levels of HDL or HDL cholesterol subfractions. Similar responses were seen in patients with both type IIb and IV lipoprotein phenotypes.

CONCLUSIONS

Because the fish oil supplement contributed negligible amounts of cholesterol and saturated fat to the diet, the n-3 fatty acids most likely caused the observed effects. These findings indicate that relatively small amounts of fish oil can have beneficial effects on plasma triglyceride levels in hypertriglyceridemic patients, but the increase in LDL cholesterol and apoprotein B levels, and in the LDL cholesterol to HDL cholesterol ratio suggests the need for careful monitoring of plasma lipoprotein changes during fish oil supplementation, and for a careful evaluation of their long-term benefits.

摘要

研究目的

确定饱和脂肪和胆固醇含量低的鱼油补充剂对高甘油三酯血症患者血浆脂质和脂蛋白水平的影响。

设计

单盲、安慰剂对照(红花油)、为期6周治疗期的交叉试验。

地点

大学医学中心的门诊脂质诊所。

患者

11名成年患者患有单纯性高甘油三酯血症(IV型),7名患者伴有高胆固醇血症(IIb型)。

干预措施

在每个治疗期,每天服用12粒1克装的鱼油胶囊或安慰剂(红花油)。

测量指标及主要结果

在每个治疗期的第5周和第6周采集血液,分析总脂质;极低密度脂蛋白、低密度脂蛋白(LDL)和高密度脂蛋白(HDL)中的胆固醇(mmol/L);以及载脂蛋白B(mg/dL)。与安慰剂相比,鱼油降低了血浆甘油三酯水平(从4.0±1.8降至2.5±1.0),升高了LDL胆固醇水平(从3.7±1.75升至4.25±0.85)、载脂蛋白B水平(从122±29升至140±34)以及LDL胆固醇与HDL胆固醇的比值(从4.0±0.9升至4.7±1.4)(P<0.05;均值±标准差)。HDL或HDL胆固醇亚组分水平未见显著变化。IIb型和IV型脂蛋白表型的患者有相似的反应。

结论

由于鱼油补充剂对饮食中胆固醇和饱和脂肪的贡献可忽略不计,n-3脂肪酸很可能是导致观察到的效果的原因。这些发现表明,相对少量的鱼油对高甘油三酯血症患者的血浆甘油三酯水平可能有有益影响,但LDL胆固醇和载脂蛋白B水平以及LDL胆固醇与HDL胆固醇比值的升高表明,在补充鱼油期间需要仔细监测血浆脂蛋白变化,并仔细评估其长期益处。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验